Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Jan. 20, 2022, 8:42 a.m. EST

NIH says Pfizer's Paxloid should be first treatment option for certain COVID-19 patients

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Pfizer Inc. (PFE)
  • X
    Merck & Co. Inc. (MRK)
  • X
    GSK PLC ADR (GSK)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

The National Institutes of Health on Wednesday updated its COVID-19 treatment guidelines for patients with mild to moderate forms of COVID-19 who are at high risk for disease progression. The new guidelines now include the recently authorized antivirals developed by Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.49% and Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -1.37% /Ridgeback Biotherapeutics, note that GlaxoSmithKline /zigman2/quotes/209463850/composite GSK -0.78% and Vir Biotechnology Inc.'s /zigman2/quotes/214486077/composite VIR +0.74% sotrovimab is the only monoclonal antibody that is thought to be effective against omicron, and have added a three-day course of Gilead Sciences Inc.'s /zigman2/quotes/210293917/composite GILD -0.42% Veklury as a treatment option. The panel suggests that clinicians first use Pfizer's Paxlovid, then sotrovimab, then Veklury, and the final option should be molnupiravir, which is the Merck/Ridgeback drug.

/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 53.15
-0.26 -0.49%
Volume: 10.78M
May 25, 2022 12:43p
P/E Ratio
12.20
Dividend Yield
3.01%
Market Cap
$299.68 billion
Rev. per Employee
$1.17M
loading...
/zigman2/quotes/209956077/composite
US : U.S.: NYSE
$ 93.34
-1.30 -1.37%
Volume: 3.59M
May 25, 2022 12:43p
P/E Ratio
16.69
Dividend Yield
2.96%
Market Cap
$239.33 billion
Rev. per Employee
$799,500
loading...
/zigman2/quotes/209463850/composite
US : U.S.: NYSE
$ 44.65
-0.35 -0.78%
Volume: 3.29M
May 25, 2022 12:43p
P/E Ratio
16.18
Dividend Yield
4.48%
Market Cap
$112.94 billion
Rev. per Employee
$552,510
loading...
/zigman2/quotes/214486077/composite
US : U.S.: Nasdaq
$ 22.99
+0.17 +0.74%
Volume: 242,736
May 25, 2022 12:43p
P/E Ratio
2.55
Dividend Yield
N/A
Market Cap
$3.02 billion
Rev. per Employee
$5.24M
loading...
/zigman2/quotes/210293917/composite
US : U.S.: Nasdaq
$ 64.08
-0.27 -0.42%
Volume: 2.73M
May 25, 2022 12:43p
P/E Ratio
17.90
Dividend Yield
4.56%
Market Cap
$80.72 billion
Rev. per Employee
$1.91M
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.